Apyx Medical Corporation (APYX)

NASDAQ: APYX · Real-Time Price · USD

2.810

-0.080 (-2.77%)

At close: Nov 13, 2026, 4:00 PM EST

2.800

-0.010 (-0.36%)

After-hours: Nov 13, 2026, 7:30 PM EST

Apyx Medical Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	59.57	52.84	48.1	52.35	44.51	48.52
Revenue Growth	24.35%	9.86%	-8.11%	17.61%	-8.26%	75.08%
Gross Profit	37.8	33.04	29.36	33.76	29.13	33.6
Operating Income	-3.28	-6.45	-18.85	-19.95	-23.31	-14.45
Net Income	-8.44	-11.21	-23.46	-18.71	-23.18	-15.17
Earnings Per Share	-0.19	-0.27	-0.66	-0.54	-0.67	-0.44
EPS Growth	-	-	-	-	-	-

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Surgical Aesthetics	45.33	38.61	43.38	36.8	42.99
Original Equipment Manufacturing (OEM)	7.51	9.5	8.97	7.71	5.53
Total	52.84	48.1	52.35	44.51	48.52

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	25.78	31.74	31.74	43.65	10.19	30.87
Total Debt	39.75	39.34	38.76	38.5	0.8	0.31
Net Cash (Debt)	-13.97	-7.6	-7.02	5.15	9.4	30.57
Net Cash Growth	-	-	-	-45.18%	-69.26%	-25.88%
Net Cash Per Share	-0.32	-0.18	-0.20	0.15	0.27	0.89

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-8.23	-8	-18.05	-5.25	-20.28	-10.45
Capital Expenditures	-0.67	-1.11	-0.72	-0.53	-1.01	-0.72
Free Cash Flow	-8.89	-9.12	-18.77	-5.78	-21.29	-11.17
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	63.45%	62.53%	61.04%	64.49%	65.45%	69.26%
Operating Margin	-5.50%	-12.20%	-39.18%	-38.11%	-52.38%	-29.78%
Pretax Margin	-13.07%	-20.50%	-48.45%	-40.65%	-51.47%	-30.55%
Profit Margin	-14.16%	-21.21%	-48.78%	-35.75%	-52.09%	-31.27%
FCF Margin	-14.93%	-17.25%	-39.02%	-11.04%	-47.83%	-23.03%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	267.00	267.00	267.00	267.00	267.00
PS Ratio	1.99	2.72	1.24	1.73	1.82	9.07